The combination of intranasal insulin (INI ... including GLP1 receptor agonists and non-pharmacologic interventions, which ...

Hypoglycemia is an extremely common side effect of insulin therapy experienced mainly by patients with type 1 diabetes ...

By measuring activation of the insulin receptor and two enzymes in the pathway, the authors showed that NNC2215 stimulated receptor signalling in cultured cells. Other experiments revealed that ...

A new study published in the journal PNAS offers insights into the biological mechanism behind this connection. Using fruit ...

Weight loss interventions are associated with improvement in some features of polycystic ovary syndrome (PCOS), according to ...

How our nose “knows”: Unraveling the biology behind our sense of smell The human nose teems with some 400 different receptors ...

Peptides have become an increasingly important area of research in numerous scientific fields, especially for their diverse functions.

Lexaria Bioscience (LEXX) provides the following glucagon-like peptide-1 industry update. It is no surprise that Novo Nordisk’s ...

Lexaria's strategy is to continue developing and optimizing our wholly-owned DehydraTECH™ drug delivery platform for application in the GLP-1 space, positioning it as a 'must-have' technology for ...

For the past two decades, study author Marc Tatar, a professor of biology affiliated with the Center on the Biology of Aging at Brown University, has studied how the hormones insulin and insulin ...

The success surrounding the medications for obesity and diabetes has sparked research into whether they could also be an ...